+Compare
ACET
Stock ticker:
NASDAQ
AS OF
Jul 1 closing price
Price
$14.68
Change
+$0.08 (+0.55%)
Capitalization
587.26M

ACET Price Prediction, Adicet Bio AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Jul 01, 2022

Momentum Indicator for ACET turns positive, indicating new upward trend

ACET saw its Momentum Indicator move above the 0 level on June 24, 2022. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 66 similar instances where the indicator turned positive. In 57 of the 66 cases, the stock moved higher in the following days. The odds of a move higher are at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ACET just turned positive on May 27, 2022. Looking at past instances where ACET's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

ACET moved above its 50-day moving average on June 24, 2022 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ACET crossed bullishly above the 50-day moving average on June 30, 2022. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACET advanced for three days, in of 208 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 128 cases where ACET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACET declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ACET broke above its upper Bollinger Band on June 24, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ACET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.888) is normal, around the industry mean (24.469). P/E Ratio (6.061) is within average values for comparable stocks, (93.841). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.919). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (13.624) is also within normal values, averaging (306.529).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACET’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

ACET is expected to report earnings to fall 549.80% to -44 cents per share on August 11

Adicet Bio ACET Stock Earnings Reports
Q2'22
Est.
$-0.45
Q1'22
Beat
by $0.28
Q4'21
Missed
by $0.05
Q3'21
Missed
by $0.01
Q2'21
Beat
by $0.18
The last earnings report on May 12 showed earnings per share of 10 cents, beating the estimate of -18 cents. With 288.92K shares outstanding, the current market capitalization sits at 587.26M.
AI
A.I.Advisor
published Dividends

ACET paid dividends on October 09, 2018

Adicet Bio ACET Stock Dividends
А quarterly dividend of $0.01 per share was paid with a record date of October 09, 2018, and an ex-dividend date of September 21, 2018. Read more...
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Global Blood Therapeutics (NASDAQ:GBT), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 1.73B. The market cap for tickers in the group ranges from 2.5K to 250.34B. NONOF holds the highest valuation in this group at 250.34B. The lowest valued company is IMUND at 2.5K.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -0%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was -36%. EVFM experienced the highest price growth at 145%, while PCNTD experienced the biggest fall at -81%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -54%. For the same stocks of the Industry, the average monthly volume growth was 1% and the average quarterly volume growth was -31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 85
Price Growth Rating: 68
SMR Rating: 93
Profit Risk Rating: 94
Seasonality Score: -18 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

a distributor of pharmaceutical intermediate ingrediants and other industrial chemicals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Distributors
Address
200 Clarendon Street
Phone
+1 650 503-9095
Employees
102
Web
https://www.adicetbio.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGLAX17.810.09
+0.51%
American Funds Global Insight R-1
EISIX17.380.04
+0.23%
Carillon ClariVest Intl Stock I
MSQLX12.290.01
+0.08%
Morgan Stanley Inst International Eq L
KGIIX13.360.01
+0.07%
Kopernik International I
RVPIX5.67N/A
N/A
Royce Smaller-Companies Growth Instl

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with IBRX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then IBRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
+0.55%
IBRX - ACET
54%
Loosely correlated
+7.26%
RARE - ACET
53%
Loosely correlated
+5.01%
SEER - ACET
52%
Loosely correlated
+9.61%
INSM - ACET
51%
Loosely correlated
+5.93%
ADPT - ACET
50%
Loosely correlated
+4.08%
More